Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01479244
Title Efficacy and Safety Study of NeuVax (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Galena Biopharma, Inc.
Age Groups: adult
Covered Countries USA | GBR | FRA | DEU | CAN

No variant requirements are available.